BLAS
GIL EXTREMERA
Investigador en el periodo 2018-2019
Brigham and Women's Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (4)
2019
-
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628
2018
-
Alirocumab and cardiovascular outcomes after acute coronary syndrome
New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107
2016
-
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study
Journal of the American Heart Association, Vol. 5, Núm. 9
2013
-
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
New England Journal of Medicine, Vol. 369, Núm. 14, pp. 1317-1326